• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, November 16, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Telomere and Exome Testing Identify Inherited Risks in Interstitial Lung Disease

by
November 12, 2026
in Health
Reading Time: 3 mins read
0
Telomere and Exome Testing Identify Inherited Risks in Interstitial Lung Disease

Telomere and Exome Testing Identify Inherited Risks in Interstitial Lung Disease

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A prospective observational cohort study evaluating European Respiratory Society guidelines found that combining whole-exome sequencing with quantitative telomere length assessment identified pathogenic variants or clinically relevant telomere shortening in patients with interstitial lung disease. The investigation, published in BMC Pulmonary Medicine, demonstrated that clinical selection criteria established by the European Respiratory Society effectively identify individuals who derive diagnostic benefit from specialized genetic and molecular evaluations.

The European Respiratory Society currently recommends formal genetic evaluation for carefully selected subsets of individuals presenting with interstitial lung disease. Despite the formal release of these clinical guidelines, prospective data assessing their actual diagnostic performance, clinical utility, and variant detection yield in routine clinical practice had remained limited, prompting the researchers to systematically evaluate the diagnostic strategy in a prospective patient cohort.

To rigorously examine the performance of these clinical criteria, the study enrolled 52 consecutive patients diagnosed with interstitial lung disease who met at least one European Respiratory Society indication for genetic evaluation. Each enrolled participant underwent dual diagnostic testing comprising comprehensive whole-exome sequencing alongside quantitative polymerase chain reaction assays to determine relative telomere length. By analyzing both molecular datasets in parallel, the investigative team evaluated the diagnostic yield across distinct clinical indications and determined how telomere length measurements complemented standard next-generation sequencing.

Whole-exome sequencing successfully identified pathogenic or likely pathogenic genetic variants in 4 of the 52 evaluated patients, representing an overall diagnostic yield of 7.7 percent. When categorized according to the primary clinical indication for referral, the diagnostic yield varied substantially across patient subgroups. The highest yield of causative genetic variants was observed among individuals evaluated for clinical suspicion of telomere biology disorders. In contrast, the researchers identified no pathogenic or likely pathogenic variants among patients referred solely for isolated early-onset interstitial lung disease who lacked any relative carrying a known disease-causing genetic variant.

Quantitative polymerase chain reaction testing for telomere length provided crucial diagnostic findings that extended beyond the sequencing results. The molecular assay detected short telomeres, defined as a length falling below the tenth percentile, in 21.2 percent of the overall cohort, representing 11 of the 52 evaluated patients. Importantly, these abnormally short telomeres were identified in patients who harbored no identifiable pathogenic variants on whole-exome sequencing, demonstrating that quantitative telomere analysis captured clinically meaningful biological abnormalities that sequencing alone failed to uncover.

The study authors concluded that their findings substantiate the clinical utility of current European Respiratory Society recommendations for directing genetic evaluation in interstitial lung disease. Patients presenting with familial interstitial lung disease and those with clinical indicators of telomere biology disorders appear to derive the greatest diagnostic advantage from testing. Furthermore, the researchers emphasized that conducting concurrent assessments using whole-exome sequencing and quantitative telomere length measurement delivers complementary clinical insight, potentially refining the diagnostic precision and long-term clinical management of inherited interstitial lung disease.

Subject of Research: Diagnostic utility of combined exome sequencing and telomere testing in interstitial lung disease

Article Title: Clinical utility of the ERS recommendations for genetic evaluation in interstitial lung disease: a prospective cohort study

Article References: Martina, S., Eva, P., Hana, S., Jan, B., Marie, D., Malgorzata, L., Andrea, H., & Milan, M. (2026). Clinical utility of the ERS recommendations for genetic evaluation in interstitial lung disease: a prospective cohort study. BMC Pulmonary Medicine. https://doi.org/10.1186/s12890-026-04849-0

Image Credits: AI Generated

DOI: 10.1186/s12890-026-04849-0

Keywords: interstitial lung disease, European Respiratory Society, whole-exome sequencing, telomere length measurement, telomere biology disorders, quantitative PCR, pathogenic variants, familial interstitial lung disease, early-onset lung disease, diagnostic yield, prospective cohort study, inherited lung disease, short telomeres, genetic evaluation, clinical utility, BMC Pulmonary Medicine

News Source: Barbara Leach. (November 12, 2026). Telomere and Exome Testing Identify Inherited Risks in Interstitial Lung Disease. Scienmag.

Tags: BMC Pulmonary Medicineclinical utilitydiagnostic yieldearly-onset lung diseaseEuropean Respiratory Societyfamilial interstitial lung diseasegenetic evaluationinherited lung diseaseinterstitial lung diseasepathogenic variantsprospective cohort studyquantitative PCRshort telomerestelomere biology disorderstelomere length measurementwhole-exome sequencing
Share12Tweet7Share2ShareShareShare1

Related Posts

Conflict-Era Maternal Age Linked to Adult Stature Differences in Timor-Leste

Conflict-Era Maternal Age Linked to Adult Stature Differences in Timor-Leste

November 16, 2026
First-Time Blood Donors Overestimate Pain and Dizziness in Swiss Study

First-Time Blood Donors Overestimate Pain and Dizziness in Swiss Study

November 16, 2026

Prevotella copri Promotes Abdominal Aortic Aneurysm Progression by Enhancing TPX2 Lactylation

November 16, 2026

Extracellular Vesicle CD47 Promotes Immune Evasion in Diffuse Large B-Cell Lymphoma

November 16, 2026

POPULAR NEWS

  • Taxonomic Study Restores Tenumembrana fallax and Names Two Cockroach Species

    Taxonomic Study Restores Tenumembrana fallax and Names Two Cockroach Species

    29 shares
    Share 12 Tweet 7
  • Vertebrobasilar Dolichoectasia Linked to Cognitive Impairment After Acute Ischemic Stroke

    29 shares
    Share 12 Tweet 7
  • Healthcare Professionals Favor Hybrid Formats for Geriatric Education in Multinational Survey

    29 shares
    Share 12 Tweet 7
  • Three New Species of Wood-Decaying Fungi Identified in Chinese Forests

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Conflict-Era Maternal Age Linked to Adult Stature Differences in Timor-Leste

Endangered Chilean Tree Legrandia Concinna Proves Very Flammable Under Laboratory Testing

First-Time Blood Donors Overestimate Pain and Dizziness in Swiss Study

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 87 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.